287 related articles for article (PubMed ID: 7528753)
41. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures.
Canalis E; Gabbitas B
J Bone Miner Res; 1994 Dec; 9(12):1999-2005. PubMed ID: 7872067
[TBL] [Abstract][Full Text] [Related]
42. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells.
Marom R; Shur I; Solomon R; Benayahu D
J Cell Physiol; 2005 Jan; 202(1):41-8. PubMed ID: 15389528
[TBL] [Abstract][Full Text] [Related]
43. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
Yeh LC; Adamo ML; Olson MS; Lee JC
Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
[TBL] [Abstract][Full Text] [Related]
44. Retinoic acid suppresses the osteogenic differentiation capacity of murine osteoblast-like 3/A/1D-1M cell cultures.
Cohen-Tanugi A; Forest N
Differentiation; 1998 Jul; 63(3):115-23. PubMed ID: 9697305
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
[TBL] [Abstract][Full Text] [Related]
46. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors.
Long MW; Robinson JA; Ashcraft EA; Mann KG
J Clin Invest; 1995 Feb; 95(2):881-7. PubMed ID: 7860771
[TBL] [Abstract][Full Text] [Related]
47. Preliminary characterization of porcine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor.
Thomson BM; Bennett J; Dean V; Triffitt J; Meikle MC; Loveridge N
J Bone Miner Res; 1993 Oct; 8(10):1173-83. PubMed ID: 8256654
[TBL] [Abstract][Full Text] [Related]
48. Phenotypic characterization of the 3/A/1D-1M osteogenic cell line derived from in vivo transplantation of 3/A/1D-1 chondroprogenitor murine teratocarcinoma cells.
Cohen-Tanugi A; Bolle M; Boy-Lefèvre ML; Anagnostou F; Forest N
Differentiation; 1996 Sep; 60(5):327-37. PubMed ID: 8855376
[TBL] [Abstract][Full Text] [Related]
49. Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo.
Benayahu D; Kletter Y; Zipori D; Wientroub S
J Cell Physiol; 1989 Jul; 140(1):1-7. PubMed ID: 2544612
[TBL] [Abstract][Full Text] [Related]
50. Effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of decorin and biglycan by cultured osteoblastic cells.
Takagi M; Yamada T; Kamiya N; Kumagai T; Yamaguchi A
Histochem J; 1999 Jun; 31(6):403-9. PubMed ID: 10462226
[TBL] [Abstract][Full Text] [Related]
51. Development and characterization of a conditionally transformed adult human osteoblastic cell line.
Bodine PV; Trailsmith M; Komm BS
J Bone Miner Res; 1996 Jun; 11(6):806-19. PubMed ID: 8725178
[TBL] [Abstract][Full Text] [Related]
52. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.
Yamaguchi A; Katagiri T; Ikeda T; Wozney JM; Rosen V; Wang EA; Kahn AJ; Suda T; Yoshiki S
J Cell Biol; 1991 May; 113(3):681-7. PubMed ID: 1849907
[TBL] [Abstract][Full Text] [Related]
53. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells.
Wergedal JE; Mohan S; Lundy M; Baylink DJ
J Bone Miner Res; 1990 Feb; 5(2):179-86. PubMed ID: 2156409
[TBL] [Abstract][Full Text] [Related]
54. Insulinlike growth factor 1 regulates mRNA levels of osteonectin and pro-alpha 1(I)-collagen in clonal preosteoblastic calvarial cells.
Thiebaud D; Ng KW; Findlay DM; Harker M; Martin TJ
J Bone Miner Res; 1990 Jul; 5(7):761-7. PubMed ID: 2204253
[TBL] [Abstract][Full Text] [Related]
55. Retinoic acid causes a decline in TGF-alpha expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line.
Dmitrovsky E; Moy D; Miller WH; Li A; Masui H
Oncogene Res; 1990; 5(3):233-9. PubMed ID: 2320376
[TBL] [Abstract][Full Text] [Related]
56. Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3-E1).
Linkhart S; Mohan S; Linkhart TA; Kumegawa M; Baylink DJ
J Cell Physiol; 1986 Aug; 128(2):307-12. PubMed ID: 3733891
[TBL] [Abstract][Full Text] [Related]
57. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.
Benvenuti S; Tanini A; Frediani U; Bianchi S; Masi L; Casano R; Bufalino L; Serio M; Brandi ML
J Bone Miner Res; 1991 Sep; 6(9):987-96. PubMed ID: 1665005
[TBL] [Abstract][Full Text] [Related]
58. A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome.
Bodo M; Baroni T; Carinci F; Becchetti E; Bellucci C; Conte C; Pezzetti F; Evangelisti R; Tognon M; Carinci P
Eur J Cell Biol; 1999 May; 78(5):323-30. PubMed ID: 10384983
[TBL] [Abstract][Full Text] [Related]
59. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells.
Gazit D; Ebner R; Kahn AJ; Derynck R
Mol Endocrinol; 1993 Feb; 7(2):189-98. PubMed ID: 8385738
[TBL] [Abstract][Full Text] [Related]
60. Human bone cell phenotypes differ depending on their skeletal site of origin.
Kasperk C; Wergedal J; Strong D; Farley J; Wangerin K; Gropp H; Ziegler R; Baylink DJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2511-7. PubMed ID: 7629252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
